Shawn Cross, Chief Financial Officer at Pacira BioSciences, Inc. (PCRX), sold 24,120 shares at $22.09 ($533K) on 2025-11-10, disclosed to the SEC on 2025-11-13.
Scheduled sale ($533k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.09 | 12,060 | $266K | 50.0% |
| 2 | $22.09 | 12,060 | $266K | 50.0% |
| Total | $22.09 avg | 24,120 | $533K | 100% |
| Filing → |
| PCRX | SELL | 2025-12-11 | $1.3M | — | Filing → |
| AMTI | SELL | 2023-11-24 | $18K | — | Filing → |
| AMTI | SELL | 2023-11-16 | $14K | — | Filing → |